Limiting the lung damage of critically ill ventilated COVID-19 patients
Friday, July 9, 2021 
12. COVID-19, 1-hour Symposium 
    12c. Clinical features, case management, outcome
    •
    2756
    •
    5:15 PM
    >
    6:15 PM
•
Limiting the lung damage of critically ill ventilated COVID-19 patients
•
12. COVID-19
12c. Clinical features, case management, outcome
 
                                 
                                            
                                            5:15 PM
                                            •
                                            2756-1
                                            •
                                            How to limit lung injury in viral induced ARDS
                                            
                                                >
                                                R.
                                                Reto
                                                SCHUEPBACH (Zurich)
                                            
                                 
                                 
                                            
                                            5:35 PM
                                            •
                                            2756-2
                                            •
                                            Pulmonary long-term sequelae in critically ill COVID-19 patients
                                            
                                                >
                                                J.
                                                Jessica
                                                GONZÁLEZ GUTIÉRREZ (Lleida)
                                            
                                 
                                 
                                            
                                            5:55 PM
                                            •
                                            2756-3
                                            •
                                            Q&A/Discussion
                                  
    
    
	 
    
                            
                             
                          
                      |